# Gate Review Package V0.1 - OpenEMR IM Core

## 1. Purpose

This document defines the Gate Review Package V0.1 for OpenEMR IM Core.

The purpose is to collect and assess the documentation-stage governance package created across PR #92 through PR #108 and determine whether the project may proceed to the next controlled planning phase.

This document is documentation-stage only.

Golden rule:

The system must support clinicians. It must not replace clinicians.

---

## 2. Document Status and Identity

| Field | Value |
|---|---|
| Document | Gate Review Package V0.1 |
| Project | OpenEMR IM Core |
| Stage | Documentation-stage gate review |
| Version | v0.1 |
| Scope | Gate review package only |
| Owner Role | Governance Owner / Release Owner |
| Reviewer Roles | Documentation Owner, Clinical Safety Owner, Human Factors Reviewer, Privacy/Security Owner, Technical Owner, Operations Owner, Claims Owner |
| Runtime Status | No runtime implementation |
| Gate Status | Review package only |
| Clinical Use Status | Not for clinical use |

This document does not authorize runtime implementation by itself.

This document does not authorize clinical, pilot, production, or commercial use.

---

## 3. Scope

This gate review package covers:

- Documentation package summary.
- Document inventory.
- Evidence availability.
- Boundary review.
- Stop-rule review.
- Claims review.
- Risk and safety review summary.
- Security and privacy review summary.
- Data governance review summary.
- Human factors review summary.
- Integration and architecture review summary.
- Non-production planning review summary.
- Training and support review summary.
- Commercial claims review summary.
- Gate decision recommendation.
- Conditions for proceeding to the next phase.

---

## 4. Out of Scope

This document does not include:

- Runtime implementation.
- SQL execution.
- Database migration.
- FHIR/API implementation.
- Frontend implementation.
- AI implementation.
- OpenEMR core-sensitive changes.
- PHI.
- Real patient data.
- Credentials.
- Secrets.
- Sensitive logs.
- Database dumps.
- Live RBAC configuration.
- Live audit implementation.
- Live backup execution.
- Live restore testing.
- Clinical validation.
- Usability validation.
- Human factors validation.
- Regulatory compliance.
- Cybersecurity certification.
- Pilot execution.
- Production release.
- Commercial deployment.

This document does not claim:

- Demo readiness.
- Pilot readiness.
- Production readiness.
- Commercial readiness.
- Clinical validation.
- Human factors validation.
- Usability validation.
- Regulatory compliance.
- Cybersecurity certification.
- HIPAA compliance.
- GDPR compliance.
- FDA readiness.
- MDR readiness.
- Medical-device readiness.

---

## 5. Gate Review Principle

A gate review determines whether the current project stage has enough documented control to proceed to the next controlled phase.

A gate decision must be based on:

- Documented scope.
- Documented boundaries.
- Documented evidence.
- Documented risks.
- Documented stop rules.
- Documented reviewer expectations.
- Documented unresolved gaps.
- Explicit decision rationale.

A gate decision must not be treated as proof of clinical validation, regulatory compliance, production readiness, commercial readiness, or cybersecurity certification.

---

## 6. Gate Decision Options

Allowed gate decisions:

| Decision | Meaning |
|---|---|
| GO | Proceed to next phase with no blocking conditions |
| CONDITIONAL GO | Proceed only within documented conditions and unresolved gaps |
| NO-GO | Do not proceed until blocking gaps are resolved |

For this documentation-stage review, the recommended decision is:

CONDITIONAL GO to Phase 2 Controlled Design Roadmap.

Reason:

The documentation-stage governance package is strong enough to support controlled design planning, but not sufficient for runtime implementation, sandbox execution, pilot, production, commercial use, clinical validation, or regulatory claims.

---

## 7. Current Gate Recommendation

Recommended decision:

CONDITIONAL GO.

Recommended next phase:

Phase 2 Controlled Design Roadmap.

Permitted next activity:

- Controlled design planning.
- Requirements baseline planning.
- Data flow diagram planning.
- Verification plan planning.
- Controlled prototype boundary planning.
- Non-production sandbox authorization planning.
- First implementation candidate review planning.

Not permitted by this gate:

- Runtime implementation.
- Production deployment.
- Clinical use.
- Pilot use.
- Commercial use.
- Real patient data use.
- PHI use.
- AI implementation.
- FHIR/API implementation.
- Frontend implementation.
- SQL or database migration.
- Claims of validation, compliance, certification, or readiness.

---

## 8. Documentation Inventory Reviewed

| PR | Document / Area | Status |
|---|---|---|
| #92 | Evidence Registry and Evidence Templates V0.1 | Reviewed for current stage |
| #93 | Traceability Matrix V0.1 | Reviewed for current stage |
| #94 | Risk Register V0.1 | Reviewed for current stage |
| #95 | Pull Request Template and Stop Rules V0.1 | Reviewed for current stage |
| #96 | Clinical Safety Case V0.1 | Reviewed for current stage |
| #97 | Human Factors and Usability Risk Plan V0.1 | Reviewed for current stage |
| #98 | Security / Privacy / RBAC / Audit / Backup Gap Refinement V0.1 | Reviewed for current stage |
| #100 | E2E birthday reminder blocker fix | Reviewed as separate runtime fix context |
| #101 | Threat Model and Data Governance V0.1 | Reviewed for current stage |
| #102 | OpenEMR Integration Boundary Map V0.1 | Reviewed for current stage |
| #103 | ADR Baseline V0.1 | Reviewed for current stage |
| #104 | Non-Production Reproducible Install Plan V0.1 | Reviewed for current stage |
| #105 | Synthetic Demo Data and Demo Boundary V0.1 | Reviewed for current stage |
| #106 | Training and Support Package V0.1 | Reviewed for current stage |
| #107 | Commercial Claims Policy and Claims Register V0.1 | Reviewed for current stage |
| #108 | Documentation Index and Review Cadence V0.1 | Reviewed for current stage |

---

## 9. Evidence Summary

Evidence currently available:

- Documentation PR history.
- Documentation index.
- Stop rules.
- Claims boundaries.
- Risk register baseline.
- Clinical safety case baseline.
- Human factors plan baseline.
- Security/privacy gap baseline.
- Threat model and data governance baseline.
- Integration boundary map.
- ADR baseline.
- Non-production install planning.
- Synthetic demo data boundary.
- Training and support planning.
- Commercial claims policy.

Evidence not yet available:

- Runtime implementation evidence.
- Unit test evidence for IM Core runtime.
- Integration test evidence for IM Core runtime.
- Verification protocol execution evidence.
- Validation protocol execution evidence.
- Sandbox execution evidence.
- Prototype results evidence.
- Clinical validation evidence.
- Human factors validation evidence.
- Security test evidence for implemented controls.
- Backup/restore test evidence.
- Production readiness evidence.
- Pilot evidence.
- External audit closure evidence.

---

## 10. Boundary Review

The current documentation package consistently preserves the following boundaries:

- Documentation-stage only.
- No PHI.
- No real patient data.
- No secrets.
- No sensitive logs.
- No database dumps.
- No SQL.
- No database migration.
- No runtime implementation.
- No AI implementation.
- No FHIR/API implementation.
- No frontend implementation.
- No OpenEMR core-sensitive change.
- No clinical use.
- No pilot use.
- No production use.
- No commercial deployment.
- No unsupported claims.

Boundary review result:

PASS for documentation-stage gate.

---

## 11. Stop-Rule Review

Stop rules are documented across governance, demo, training, support, claims, and index documents.

Key stop rules include:

- Stop if PHI is found.
- Stop if real patient data is found.
- Stop if secrets are found.
- Stop if production credentials are found.
- Stop if unsupported readiness claims are made.
- Stop if clinical validation is implied without evidence.
- Stop if runtime implementation appears without gate approval.
- Stop if SQL or migration appears without approval.
- Stop if AI/CDS functionality appears without explicit authorization.
- Stop if frontend/workflow implementation appears without human factors review.

Stop-rule review result:

PASS for documentation-stage gate.

---

## 12. Risk Review Summary

Risk documentation exists at baseline level.

Current strengths:

- Risk register exists.
- Safety, privacy, claims, demo, training, and support risks are repeatedly bounded.
- Stop rules are documented.
- Risk escalation expectations are defined.

Current limitations:

- No implemented risk controls have been verified.
- No residual risk has been validated against runtime behavior.
- No production or post-deployment risk monitoring exists.
- No clinical use risk evidence exists.

Risk review result:

PASS for controlled design planning.

NO-GO for runtime, clinical, pilot, production, or commercial use.

---

## 13. Clinical Safety Review Summary

Clinical safety documentation exists at baseline level.

Current strengths:

- Clinician authority is preserved.
- Replacement of clinician judgment is prohibited.
- Diagnosis, prescribing, and emergency triage are not authorized.
- Clinical validation is not claimed.

Current limitations:

- No implemented clinical workflow exists.
- No clinical safety verification evidence exists.
- No clinical validation evidence exists.
- No real-world clinical monitoring exists.

Clinical safety review result:

PASS for controlled design planning.

NO-GO for clinical use.

---

## 14. Human Factors Review Summary

Human factors planning exists at baseline level.

Current strengths:

- Workflow and usability risks are acknowledged.
- Frontend implementation is blocked before review.
- Alert fatigue and false reassurance boundaries are recognized.
- Training and demo boundaries preserve user understanding.

Current limitations:

- No UI or workflow implementation exists.
- No usability protocol has been executed.
- No human factors validation evidence exists.
- No user testing evidence exists.

Human factors review result:

PASS for controlled design planning.

NO-GO for UI/workflow release.

---

## 15. Security and Privacy Review Summary

Security and privacy planning exists at baseline level.

Current strengths:

- No-PHI rule is consistently documented.
- Threat model and data governance exist.
- Security/privacy gaps are documented.
- Secrets, logs, screenshots, and demo data boundaries are documented.
- Claims of HIPAA/GDPR/cybersecurity certification are prohibited.

Current limitations:

- No implemented security controls are verified.
- No live RBAC implementation exists.
- No live audit implementation exists.
- No backup/restore testing exists.
- No penetration testing or vulnerability closure evidence exists.

Security/privacy review result:

PASS for controlled design planning.

NO-GO for production or compliance claims.

---

## 16. Data Governance Review Summary

Data governance planning exists at baseline level.

Current strengths:

- Synthetic-only boundaries are documented.
- PHI is prohibited.
- Demo and training data boundaries are documented.
- Screenshots, logs, and artifacts are bounded.

Current limitations:

- No real data use is authorized.
- No data retention implementation exists.
- No production data workflow exists.
- No data access control evidence exists.

Data governance review result:

PASS for synthetic-only planning.

NO-GO for real data use.

---

## 17. Architecture and Integration Review Summary

Architecture and integration planning exists at baseline level.

Current strengths:

- OpenEMR integration boundary is documented.
- ADR baseline exists.
- OpenEMR core-sensitive changes are blocked.
- SQL, FHIR/API, frontend, and runtime implementation are blocked without approval.

Current limitations:

- No implemented architecture exists.
- No data flow diagram has been approved.
- No interface control evidence exists.
- No integration verification evidence exists.

Architecture and integration review result:

PASS for controlled design planning.

NO-GO for implementation.

---

## 18. Non-Production Planning Review Summary

Non-production planning exists at baseline level.

Current strengths:

- Non-production reproducible install planning exists.
- Synthetic data boundaries are documented.
- No production credentials or production endpoints are allowed.
- Cleanup and rollback expectations are documented.

Current limitations:

- No sandbox has been authorized yet.
- No installation has been executed.
- No reproducibility evidence exists.
- No prototype results exist.

Non-production planning review result:

PASS for sandbox authorization planning.

NO-GO for sandbox execution without further approval.

---

## 19. Training and Support Review Summary

Training and support planning exists at baseline level.

Current strengths:

- Training boundaries are documented.
- Support roles and escalation principles are documented.
- PHI and unsupported claims are prohibited.
- Support readiness is not claimed.

Current limitations:

- No training has been executed.
- No support process has been activated.
- No training completion evidence exists.
- No production support model exists.

Training/support review result:

PASS for training/support planning.

NO-GO for live support readiness claim.

---

## 20. Commercial Claims Review Summary

Claims governance exists at baseline level.

Current strengths:

- Allowed and prohibited claims are documented.
- Claims register exists.
- Unsupported clinical, regulatory, security, AI, commercial, and performance claims are prohibited.
- Correction and retraction process is documented.

Current limitations:

- No commercial claim is approved.
- No legal/commercial review evidence exists.
- No customer readiness evidence exists.
- No pricing, SLA, or contracting evidence exists.

Commercial claims review result:

PASS for claims governance planning.

NO-GO for commercial readiness claim.

---

## 21. Gate Criteria

Gate criteria for documentation-stage closure:

| Criterion | Status |
|---|---|
| Evidence registry exists | Met |
| Traceability baseline exists | Met |
| Risk register baseline exists | Met |
| PR stop rules exist | Met |
| Clinical safety case exists | Met |
| Human factors plan exists | Met |
| Security/privacy gap refinement exists | Met |
| Threat model and data governance exists | Met |
| Integration boundary map exists | Met |
| ADR baseline exists | Met |
| Non-production install plan exists | Met |
| Synthetic demo data boundary exists | Met |
| Training/support package exists | Met |
| Commercial claims policy exists | Met |
| Documentation index exists | Met |
| CI green before merge for each PR | Met |
| No PHI introduced | Met |
| No runtime implementation introduced | Met |
| No unsupported readiness claim introduced | Met |

Gate criteria result:

Met for documentation-stage closure.

---

## 22. Remaining Gaps

Remaining gaps before runtime or sandbox execution:

- Phase 2 Controlled Design Roadmap not yet created.
- Data Flow Diagram Plan not yet created.
- Requirements Baseline not yet created.
- Verification Plan not yet created.
- Controlled Prototype Boundary not yet created.
- Non-Production Sandbox Authorization Package not yet created.
- First Implementation Candidate Review not yet created.
- Implementation Gate 1 not yet completed.
- No runtime code authorized.
- No sandbox execution authorized.
- No verification or validation evidence exists.

---

## 23. Recommended Next Phase

Recommended next phase:

Phase 2 Controlled Design Roadmap.

Suggested next documents:

1. Phase 2 Controlled Design Roadmap V0.1.
2. Data Flow Diagram Plan V0.1.
3. Requirements Baseline V0.1.
4. Verification Plan V0.1.
5. Controlled Prototype Boundary V0.1.
6. Non-Production Sandbox Authorization Package V0.1.
7. First Implementation Candidate Review V0.1.
8. Implementation Gate 1 V0.1.

---

## 24. Gate Decision

Final gate recommendation:

CONDITIONAL GO to Phase 2 Controlled Design Roadmap.

Conditions:

- Continue documentation-only unless a future gate explicitly authorizes implementation.
- Do not introduce PHI.
- Do not introduce real patient data.
- Do not introduce SQL or migration.
- Do not introduce FHIR/API implementation.
- Do not introduce frontend implementation.
- Do not introduce AI/CDS implementation.
- Do not introduce OpenEMR core-sensitive change.
- Do not claim clinical validation.
- Do not claim production readiness.
- Do not claim commercial readiness.
- Do not claim regulatory compliance.
- Do not claim cybersecurity certification.
- Continue one PR, one primary purpose.
- Continue requiring 0 failing / 0 pending before merge.

---

## 25. Gate Decision Rationale

The documentation package is mature enough to proceed to controlled design planning because it establishes:

- Governance baseline.
- Evidence baseline.
- Traceability baseline.
- Risk baseline.
- Clinical safety boundary.
- Human factors boundary.
- Security/privacy boundary.
- Data governance boundary.
- OpenEMR integration boundary.
- Architecture decision baseline.
- Non-production planning boundary.
- Synthetic demo boundary.
- Training/support boundary.
- Claims control.
- Documentation index and review cadence.

However, the package is not sufficient for implementation, pilot, production, commercial deployment, clinical use, validation, compliance, or certification.

---

## 26. Reviewer Checklist

Reviewers should confirm:

- Documentation-only scope.
- Correct file path.
- No PHI.
- No secrets.
- No sensitive logs.
- No database dumps.
- No SQL.
- No database migration.
- No runtime implementation.
- No frontend implementation.
- No FHIR/API implementation.
- No AI implementation.
- No OpenEMR core-sensitive change.
- No live RBAC.
- No live audit.
- No live backup.
- No live restore testing.
- Gate decision is conditional, not unrestricted.
- Gate does not claim readiness, validation, compliance, or certification.
- Remaining gaps are documented.
- Next phase is limited to controlled design planning.
- Relationship to PR #92 through PR #108 is accurate.
- Unicode/Bidi warning is checked if GitHub displays one.

---

## 27. Definition of Done

This document is complete when:

- Purpose is defined.
- Scope is defined.
- Out-of-scope is defined.
- Gate principle is documented.
- Gate decision options are documented.
- Current gate recommendation is documented.
- Documentation inventory is reviewed.
- Evidence summary is documented.
- Boundary review is documented.
- Stop-rule review is documented.
- Risk review summary is documented.
- Clinical safety review summary is documented.
- Human factors review summary is documented.
- Security/privacy review summary is documented.
- Data governance review summary is documented.
- Architecture/integration review summary is documented.
- Non-production planning review summary is documented.
- Training/support review summary is documented.
- Commercial claims review summary is documented.
- Gate criteria are documented.
- Remaining gaps are documented.
- Recommended next phase is documented.
- Gate decision is documented.
- Gate rationale is documented.
- Reviewer checklist is included.
- No PHI is introduced.
- No SQL is introduced.
- No runtime implementation is introduced.
- No unsupported readiness, validation, compliance, certification, or commercial claim is introduced.

---

## 28. After-Merge Action

After this PR is merged, the next planned documentation step is:

Phase 2 Controlled Design Roadmap V0.1.

Do not start the next PR until:

- This PR is merged.
- master is updated locally.
- Working tree is clean.
- The PR body file is removed locally.
- custom/im-core/docs/gate-review/gate-review-package-v0.1.md exists on master.

---

## 29. Status

Documentation-stage gate review package.

Gate recommendation:

CONDITIONAL GO to Phase 2 Controlled Design Roadmap.

No runtime implementation.

No SQL.

No database migration.

No PHI.

No real patient data.

No AI implementation.

No FHIR/API implementation.

No frontend implementation.

No OpenEMR core-sensitive change.

No live RBAC.

No live audit.

No live backup.

No restore testing.

Not clinically validated.

Not usability validated.

Not human factors validated.

Not regulatory compliant.

Not cybersecurity certified.

Not demo-ready.

Not pilot-ready.

Not production-ready.

Not commercially deployment-ready.
